71 results on '"Pelletier C"'
Search Results
2. The effect of hard chrome plating on iron fines formation
3. La chirurgie des endométrioses complexes dans le PMSI : aide à la décision pour la mise en place des filières régionales de prise en charge de l'endométriose
4. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
5. Wavelet-based estimation of the hemodynamic responses in diffuse optical imaging
6. A risk analysis for gas transport network planning expansion under regulatory uncertainty in Western Europe
7. Evaluation of heart failure management in a Military Hospital
8. Six methodological steps to build medical data warehouses for research
9. Facteurs influençant la prise de décision du traitement de suppléance rénale par les patients inclus dans le parcours de soins maladie rénale chronique pré-suppléance
10. Développement d’un outil de prédiction permettant d’estimer la consommation de potassium des patients suivis en néphrologie–Étude UniverSel
11. Persistance de la réponse vaccinale anti SARS-CoV-2 chez le patient hémodialysé chronique : intérêt d’un rappel à 6 mois
12. Rationnel, tolérance et immunogénicité d’une 3e dose de vaccin ARNm anti SARS-Cov2 chez les patients hémodialysés chroniques
13. Défaut de réponse humorale et cellulaire à la vaccination anti-SARS-CoV2 à ARNm chez les patients hémodialysés naïfs
14. PCN218 Burden of Illness on Patients And Caregivers and Quality of Life Outcomes of Triple-Class Exposed (TCE) Patients With Multiple Myeloma (MM) In The United States
15. PCN58 Estimation of Post-Infusion Costs of Care for Patients With Relapsed and Refractory Multiple Myeloma (RRMM) Who Received Idecabtagene Vicleucel (ide-cel, bb2121) in the KarMMa Clinical Trial
16. PCN151 IMPACT OF ADVERSE EVENTS (AES) ON HEALTHCARE RESOURCE UTILIZATION (HRU) AND TOTAL COSTS OF CARE (TCOC) AMONG PATIENTS WITH LARGE B-CELL LYMPHOMA (LBCL)
17. PND120 TREATMENT PATTERNS AMONG PATIENTS WITH MULTIPLE SCLEROSIS INITIATING SECOND-LINE DISEASE-MODIFYING THERAPY
18. PND19 PRODUCTIVITY LOSS AMONG CAREGIVERS OF PATIENTS WITH MS
19. PSS23 DISEASE BURDEN IN PATIENTS WITH MILD PSORIASIS: GROUP CONCEPT MAPPING
20. PSS15 REAL-WORLD COSTS IN BIOLOGIC NAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE
21. PSS14 REAL-WORLD COSTS IN BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE
22. PMS55 TREATMENT PATTERNS AMONG MS PATIENTS NEWLY INITIATING DISEASE-MODIFYING THERAPY
23. ND3 SHORT- AND LONG-TERM DISABILITY BURDEN AMONG EMPLOYED PATIENTS RECEIVING DISEASE-MODIFYING TREATMENT FOR MULTIPLE SCLEROSIS
24. PSS6 COMPARISON OF TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE
25. PMS37 RATES OF REAL-WORLD TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE
26. Analgésie péridurale obstétricale chez une parturiente atteinte d’un déficit en facteur XI : défi inconsidéré ou risque raisonné ?
27. PMS36 - SWITCH PATTERNS AND TOTAL HEALTHCARE COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIATIC ARTHRITIS: RESULTS FROM A US CLAIMS ANALYSIS
28. PSS23 - SWITCH PATTERNS AND TOTAL COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIASIS
29. Performances du premier test rapide IgG rougeole (Biosynex Measles) : un premier pas vers une stratégie vaccinale personnalisée
30. PSS31 - Treatment Patterns PSO
31. PMS63 - Treatment Patterns PSA
32. Mort subite et « Tako-Tsubo inversé » : rechercher une étiologie cérébroméningée !
33. PSY122 - Real World Comparison of Persistence And Adherence Among Biologic Naïve Patients Initiating Apremilast or Biologics for The Treatment of Psoriasis In The United States
34. PMS85 - Comparison of Persistence And Adherence In Biologic Naïve Patients With Psoriatic Arthritis Initiating Apremilast or Biologics In A US Administrative Claims Database
35. Altération des propriétés anti-agrégantes plaquettaires des HDL dans l’insuffisance rénale chronique : rôle de la carbonylation et du récepteur CD36
36. PV-0416: Novel methods for normal tissue dose in epidemiological studies of second cancer in radiotherapy
37. 1029P - Real-world comparative effectiveness analysis of second-line (2L) nab-paclitaxel (nab-P) vs paclitaxel (Pac) in patients (Pts) with metastatic breast cancer (MBC)
38. 1030P - Real-world comparative effectiveness analysis of second-line (2L) nab-paclitaxel (nab-P) vs eribulin (Erib) in patients (Pts) with metastatic breast cancer (MBC)
39. PCN96 - Cost-Effectiveness Analysis of Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in the United States
40. PCN53 - Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia
41. PRM249 - Capturing Quality of Life (Qol) Data in Rare Indications: Case Study in Radioiodine-Refractory Thyroid Cancer (Rr-Dtc)
42. PRM138 - Incremental Quality Adjusted Life Years (Qaly) Analysis in Absence of Head to Head and Health Related Quality of Life (Hrqol) Data: a Case Study in Thyroid Cancer
43. Reconstruction of Out-of-Field Normal Tissue Dose for Intensity Modulated Radiation Therapy Patients for Large Scale Retrospective Epidemiological Studies of Late Effects
44. Impact de la pratique d’une activité physique régulière perdialytique sur la microcirculation des membres inférieurs chez les patients hémodialysés chroniques : résultats de l’étude Activdial
45. PCN26 - Epidemiology And Treatment Of Radioactive Iodine-Refractory Differentiated Thyroid Cancer In The Eu5
46. PRM6 - Matching-Adjusted Indirec Treatment Comparison And Survival Extrapolation In Radioiodine-Refractory Differentiated Thyroid Cancer (Rai-Refractory Dtc)
47. Impact of expected and actual energy content on consumer food memory for a whole meal
48. Impact of expected and actual energy content on consumer food memory for a whole meal
49. Évaluation de la fonction rénale chez les obèses par la cystatine C
50. Exposition professionnelle des décolleteurs aux aérosols de fluides de coupe : monitoring et hygiène industrielle
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.